Healthleap Secures $38M in Funding for AI Platform Identifying At-Risk Hospital Patients
Healthleap, a South African startup developing an AI platform to identify patients at risk of undiagnosed conditions such as malnutrition and delirium, has raised $38 million across seed and Series A funding rounds. The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, followed by a $30 million Series A led by Hummingbird Ventures. Healthleap’s platform analyzes electronic health records using natural language processing to flag patients who may need closer medical attention. The company has expanded from three hospital partners in 2022 to over 50 today, including major healthcare systems like Penn Medicine and Cedars-Sinai. Its AI-driven tools are designed to improve patient outcomes by identifying issues early, leading to measurable financial benefits for hospitals—such as $23.8 million in annualized savings at the Hospital of the University of Pennsylvania. Healthleap’s revenue has grown more than 10x over the past year and it uses a combination of contract-based pricing tied to hospital size and outcome-based models that deliver significant ROI, with some customers reporting returns exceeding 20 times their investment.
Topics: ai healthtech medical_diagnosis startups